Trial Profile
Feasibility Study - Whether the Administration of the Dronabinol and PEA May Act as a Therapy for Obstructive Sleep Apnea
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 15 Sep 2021
Price :
$35
*
At a glance
- Drugs Dronabinol/palmitoylethanolamide (Primary)
- Indications Sleep apnoea syndrome
- Focus Proof of concept; Therapeutic Use
- Acronyms OSA Trial
- Sponsors SciSparc
- 18 Jun 2019 According to a Therapix Biosciences media release, the top-line results for this study are expected in the second half of 2019.
- 18 Jun 2019 Interim results(n=7) published in the Therapix Biosciences media release
- 29 May 2019 According to a Therapix Biosciences media release, interim results are expected in the third quarter of 2019.